Comparison of therapeutic effect of nigella sativa and corticosterioid in orabase on oral erosive atrophic lichen planus

Comparison of therapeutic effect of nigella sativa and corticosterioid in orabase on oral erosive atrophic lichen planus:A randomized triple blind clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080907001222N2

Enrollment

Registered

2019-03-11

Start date

2640-06-22

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lichen planus. Lichen planus

Interventions

Intervention 1: In intervention group patients will use nigella sativa orabase (5%) 3 times a day for one month. Intervention 2: Control group: In this group patients will receive routine treatment

Eligibility

Sex/Gender

All

Age

8 Years to No maximum

Inclusion criteria

Inclusion criteria: patient with oral lichen planus two oral lesions maximum 3 cm diameter

Exclusion criteria

Exclusion criteria: systemic compromised patients lesion of posterior palate and oral floor pregnant and breast feeding patients children under 8 years old patients using immunosuppressant drugs lichenoid reaction lesions nigella sativa hypersensitivity

Design outcomes

Primary

Measure	Time frame
Severity of oral lesion. Timepoint: weekly up to one month. Method of measurement: tongprasom scale.	—

Secondary

Measure	Time frame
Burning sensation. Timepoint: Pain and burning sensation will be measured before intervention and then weekly for one month. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtessa Pakfetrat

Mashhad University of Medical Sciences

pakfetrata@mums.ac.ir+98 51 3882 9501

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026